广泛蛋白组筛查揭示银屑病关节炎与无关节炎银屑病共享血清蛋白组特征
该研究采用Olink高通量平台检测PsA、Pso、AS患者及健康对照血清中951种蛋白,发现PsA与HC间有68种差异表达蛋白,但PsA与Pso直接比较无差异蛋白,提示二者共享血清蛋白组特征。肿胀关节数与ICAM-1和CCL18相关性最强,PASI评分与PI3和IL-17受体A相关性较好。
要点
- PsA与Pso患者血清蛋白组无差异,支持银屑病谱系疾病概念。
- 肿胀关节数与ICAM-1(r=0.81)和CCL18(r=0.76)强相关。
- PASI评分与PI3(r=0.54)和IL-17受体A(r=-0.51)相关。
核心结论
- PsA与Pso患者共享血清蛋白组特征,支持单一银屑病谱系疾病概念。
- 未来研究应聚焦皮肤和滑膜组织以揭示Pso发展为关节炎的局部驱动因素差异。
研究设计与样本
- 采用Olink高通量血清生物标志物平台检测951种独特蛋白。
- 纳入PsA患者20例、Pso患者18例、AS患者19例及健康对照20例。
- Pso与PsA按PASI及其他临床参数匹配。
主要发现
- PsA与HC比较发现68种差异表达蛋白(DEPs)。
- 68种DEPs中48种(71%)在Pso和/或AS中亦失调。
- PsA与Pso直接比较无差异表达蛋白。
- 层次聚类分析和多维标度显示HC与所有患者明显分离,PsA与Pso聚为一组。
- 肿胀关节数与ICAM-1(r=0.81,P<0.001)和CCL18(r=0.76,P<0.001)正相关性最强。
临床怎么用
- 血清蛋白组特征难以区分PsA与Pso,临床需结合关节影像学等评估关节炎。
- ICAM-1和CCL18与肿胀关节数强相关,或可作为关节受累的血清标志物候选。
局限性
- 样本量较小(PsA 20例、Pso 18例、AS 19例、HC 20例)。
- 仅检测血清蛋白组,未涉及皮肤和滑膜组织局部因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify novel serum proteins involved in the pathogenesis of PsA as compared with healthy controls, psoriasis (Pso) and AS, and to explore which proteins best correlated to major clinical features of the disease. METHODS: A high-throughput serum biomarker platform (Olink) was used to assess the level of 951 unique proteins in serum of patients with PsA (n = 20), Pso (n = 18) and AS (n = 19), as well as healthy controls (HC, n = 20). Pso and PsA were matched for Psoriasis Area and Severity Index (PASI) and other clinical parameters. RESULTS: We found 68 differentially expressed proteins (DEPs) in PsA as compared with HC. Of those DEPs, 48 proteins (71%) were also dysregulated in Pso and/or AS. Strikingly, there were no DEPs when comparing PsA with Pso directly. On the contrary, hierarchical cluster analysis and multidimensional scaling revealed that HC clustered distinctly from all patients, and that PsA and Pso grouped together. The number of swollen joints had the strongest positive correlation to ICAM-1 (r = 0.81, P < 0.001) and CCL18 (0.76, P < 0.001). PASI score was best correlated to PI3 (r = 0.54, P < 0.001) and IL-17 receptor A (r = -0.51, P < 0.01). There were more proteins correlated to PASI score when analysing Pso and PsA patients separately, as compared with analysing Pso and PsA patients pooled together. CONCLUSION: PsA and Pso patients share a serum proteomic signature, which supports the concept of a single psoriatic spectrum of disease. Future studies should target skin and synovial tissues to uncover differences in local factors driving arthritis development in Pso.
引用
- Leijten E, Tao W, Pouw J, et al. Broad proteomic screen reveals shared serum proteomic signature in patients with psoriatic arthritis and psoriasis without arthritis. Rheumatology (Oxford). 2021. PMID: 32793974. doi:10.1093/rheumatology/keaa405
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。